Medico Remedies Limited (NSE:MEDICO)
India
· Delayed Price · Currency is INR 47.80
-2.71 (-5.37%)
Jun 10, 2025, 3:30 PM IST
Medico Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 100.93 | 82.91 | 72.42 | 48.12 | 25.9 | Upgrade
|
Depreciation & Amortization | 30.3 | 28.79 | 27.21 | 22.18 | 16.5 | Upgrade
|
Loss (Gain) From Sale of Assets | 0 | -0.03 | 0.01 | 0.39 | - | Upgrade
|
Provision & Write-off of Bad Debts | -5.82 | 6.26 | -1.39 | 0.62 | - | Upgrade
|
Other Operating Activities | -4.02 | 1.49 | 4.91 | 0.74 | 10.8 | Upgrade
|
Change in Accounts Receivable | -69.66 | -136.13 | -55.62 | -38.81 | -274.3 | Upgrade
|
Change in Inventory | -103.89 | 33.62 | -15.91 | -35.57 | -145.5 | Upgrade
|
Change in Accounts Payable | 32.01 | 5.26 | 38.89 | 17.49 | 253.5 | Upgrade
|
Change in Other Net Operating Assets | 69.06 | 4.66 | 11.16 | 43.46 | - | Upgrade
|
Operating Cash Flow | 48.92 | 26.83 | 81.67 | 58.62 | -113.1 | Upgrade
|
Operating Cash Flow Growth | 82.36% | -67.15% | 39.32% | - | - | Upgrade
|
Capital Expenditures | -31.85 | -24.78 | -65.92 | -59.13 | -169.6 | Upgrade
|
Sale of Property, Plant & Equipment | 0.04 | 0.08 | 0.05 | 30.1 | - | Upgrade
|
Investment in Securities | -0.88 | -0.98 | -0.87 | -0.14 | - | Upgrade
|
Other Investing Activities | 1.05 | -1.09 | 0.71 | 0.6 | - | Upgrade
|
Investing Cash Flow | -34.6 | -26.77 | -66.04 | -17.56 | -169.6 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 101 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 49.5 | Upgrade
|
Total Debt Issued | - | - | - | - | 150.5 | Upgrade
|
Long-Term Debt Repaid | -5.2 | -4.9 | -4.6 | -1.5 | - | Upgrade
|
Net Debt Issued (Repaid) | -5.2 | -4.9 | -4.6 | -1.5 | 150.5 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 41.5 | Upgrade
|
Other Financing Activities | - | - | -13.57 | -56.21 | -9.2 | Upgrade
|
Financing Cash Flow | -5.2 | -4.9 | -18.17 | -57.71 | 182.8 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | -2.45 | - | - | - | Upgrade
|
Net Cash Flow | 9.12 | -7.29 | -2.54 | -16.65 | -99.9 | Upgrade
|
Free Cash Flow | 17.07 | 2.04 | 15.75 | -0.51 | -282.7 | Upgrade
|
Free Cash Flow Growth | 735.32% | -87.02% | - | - | - | Upgrade
|
Free Cash Flow Margin | 1.13% | 0.14% | 1.12% | -0.04% | -23.10% | Upgrade
|
Free Cash Flow Per Share | 0.21 | 0.03 | 0.19 | -0.01 | -3.41 | Upgrade
|
Cash Interest Paid | - | - | 0.53 | 2.33 | 9.2 | Upgrade
|
Cash Income Tax Paid | 38.02 | 31.66 | 24.95 | 17.95 | 9.3 | Upgrade
|
Levered Free Cash Flow | -83.07 | -12.64 | -18.61 | -11.65 | -163.84 | Upgrade
|
Unlevered Free Cash Flow | -75.83 | -8.63 | -14.99 | -8.48 | -158.9 | Upgrade
|
Change in Net Working Capital | 149.11 | 75.33 | 19.39 | 3.76 | 28.24 | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.